A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise

Original Research

(3173) Views  (977) Full article downloads

Authors: Linda S Pescatello, Bruce E Blanchard, Gregory J Tsongalis, Ann A O’Connell, Heather Gordish-Dressman, et al

Published Date September 2008 Volume 2008:1 Pages 7 - 17

DOI: http://dx.doi.org/10.2147/TACG.S3813

Linda S Pescatello¹, Bruce E Blanchard², Gregory J Tsongalis³, Ann A O’Connell⁴, Heather Gordish-Dressman⁵, Carl M Maresh¹, Paul D Thompson⁶

¹Department of Kinesiology, University of Connecticut, Storrs, CT, USA; ²Department of Pathology; ³Department of Pathology, Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA; ⁴School of Educational Policy and Leadership, Ohio State University, Columbus, OH, USA; ⁵Research Center for Genetic Medicine, Children’s National Medical Center, Washington, DC, USA; ⁶Division of Cardiology, Hartford Hospital, Hartford, CT, USA

Abstract: We compared the genetic and clinical profile of men who lower and do not lower blood pressure (BP) after acute aerobic exercise. Volunteers were 45 men (Mean ± SEM, 43.5 ± 1.5 yr) with high BP (145.7 ± 1.5/85.7 ± 1.1 mmHg). They completed three experiments: nonexercise control and two cycle exercise sessions at 40% and 60% peak oxygen consumption, and were then instrumented to an ambulatory BP monitor. Logistic regression determined the genetic and clinical profile of men who lowered BP after exercise (responders [ExR n = 36]); and those who did not (nonresponders [ExNR n = 9]). ExR had higher C-reactive protein (CRP), high-density lipoprotein (HDL), the metabolic syndrome, family history of hypertension, more renin-angiotensin system (RAS) common alleles, and α-adducin Trp⁴⁶⁰ and endothelial nitric oxide synthase (ENOS) C⁷⁸⁶ risk alleles. ExNR had lower CRP and HDL, did not have the metabolic syndrome and a family history of hypertension, had more RAS risk alleles, and had the α-adducin Gly460Gly and ENOS T786T genotypes. This model had a sensitivity of 97.1%, specificity of 75.0%, and accounted for 46.3%–74.4% of the BP response. These results suggest genetic and clinical information may eventually be used to characterize people who do and do not respond to exercise as antihypertensive therapy.

Keywords: blood pressure, genetics, hypertension, metabolic syndrome, physical activity